Patents Assigned to Smith Kline Dauelsberg GmbH
  • Patent number: 5057319
    Abstract: The present invention provides a pharmaceutical granule composition comprising cimetidine and, as a granulating agent and taste-masking agent, an ester of a polyhydroxy compound, and where desired a palatable pharmaceutically acceptable emulsifier. Particular esters are glycerol esters. The granules of the present invention can be used in the preparation of chewable tablets which have good palatability and bioavailability.
    Type: Grant
    Filed: December 20, 1988
    Date of Patent: October 15, 1991
    Assignee: Smith Kline Dauelsberg GmbH
    Inventors: Eberhard F. Gottwald, Hermann P. Osterwald, Horst M. Machoczek, David Mayron
  • Patent number: 4861592
    Abstract: A pharmaceutical composition suitable for oral adminstration comprising particulate cimetidine suspended in an aqueous phase containing a buffer which maintains the pH at greater than 7 and a suspending agent.
    Type: Grant
    Filed: June 2, 1987
    Date of Patent: August 29, 1989
    Assignee: Smith Kline Dauelsberg GmbH
    Inventors: Eberhard F. Gottwald, Horst M. Machoczek
  • Patent number: 4851443
    Abstract: Amide derivatives of non-steroidal anti-inflammatory carboxylic acids which have anti-inflammatory activity in their own right as well as being effective as pro-drugs of the carboxylic acids.
    Type: Grant
    Filed: July 5, 1988
    Date of Patent: July 25, 1989
    Assignee: Smith Kline Dauelsberg, GmbH
    Inventor: Kay Brune
  • Patent number: 4783487
    Abstract: Amide derivatives of non-steroidal anti-inflammatory carboxylic acids which have anti-inflammatory activity in their own right as well as being effective as pro-drugs of the carboxylic acids.
    Type: Grant
    Filed: March 13, 1986
    Date of Patent: November 8, 1988
    Assignee: Smith Kline Dauelsberg GmbH
    Inventor: Kay Brune